Co-staining of bone tissue sections with SA-βGal and Emcn also showed markedly increased percentage of SA-βGal-expressing blood vessels in metaphysis in MPS-treated mice relative to vehicle-treated mice (Supplementary Fig. 3a, b). This evidence concerns the gene EMCN and mucopolysaccharidosis.